5,344 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Purchased by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 5,344 shares of the exchange traded fund’s stock, valued at approximately $528,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after acquiring an additional 18,202 shares in the last quarter. Jane Street Group LLC increased its holdings in shares of SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after purchasing an additional 391,333 shares during the period. Bessemer Group Inc. lifted its position in shares of SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after purchasing an additional 15,794 shares in the last quarter. Finally, Employees Retirement System of Texas boosted its holdings in shares of SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after purchasing an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $104.18 on Monday. The firm’s 50 day moving average price is $98.96 and its two-hundred day moving average price is $95.68. The firm has a market cap of $7.94 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $64.99 and a twelve month high of $104.22.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.